PHK
LGND icon

Point72 Hong Kong’s Ligand Pharmaceuticals LGND Stock Holding History

Point72 Hong Kong’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,090
Closed -$59K – 953
2022
Q3 		$59K Buy
+1,090
New +$64.1K ﹤0.01% 1381
2022
Q1 		– Sell
-208
Closed -$20K – 2115
2021
Q4 		$20K Buy
+208
New +$19.2K ﹤0.01% 1542
2021
Q2 		– Sell
-345
Closed -$33K – 2158
2021
Q1 		$33K Sell
345
-434
-56% -$41K ﹤0.01% 1369
2020
Q4 		$48K Buy
779
+329
+73% +$18.8K ﹤0.01% 1232
2020
Q3 		$27K Buy
+450
New +$30.7K ﹤0.01% 812
2020
Q2 		– Sell
-202
Closed -$9K – 1304
2020
Q1 		$9K Buy
+202
New +$11.4K ﹤0.01% 703
2019
Q4 		– Sell
-24
Closed -$1K – 1323
2019
Q3 		$1K Sell
24
-31
-56% -$1.95K ﹤0.01% 910
2019
Q2 		$4K Buy
+55
New +$4.05K ﹤0.01% 952
2019
Q1 		– Sell
-11
Closed -$1K – 1159
2018
Q4 		$1K Buy
+11
New +$1.17K ﹤0.01% 798
2017
Q1 		– Sell
-199
Closed -$13K – 854
2016
Q4 		$13K Buy
+199
New +$12.6K 0.01% 611

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Hong Kong's LGND Position: Q4 2022 in Review

Point72 Hong Kong sold out of Ligand Pharmaceuticals (LGND) in Q4 2022, closing a stake of 1,090 shares — an estimated $59K sold.

Point72 Hong Kong first reported a position in LGND in Q4 2016 and held it in 10 quarters. The position peaked at $59K in Q3 2022. 198 funds tracked by Wall St. Rank hold LGND as of Q4 2022.

  • Point72 Hong Kong reported no remaining Ligand Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 1,090 Ligand Pharmaceuticals shares in Q4 2022, an estimated $59K.
  • Point72 Hong Kong first reported a position in Ligand Pharmaceuticals in Q4 2016 and held it in 10 quarters.
  • Point72 Hong Kong's Ligand Pharmaceuticals position peaked at $59K in Q3 2022.
  • 198 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.